FIM
GILD icon

FWL Investment Management’s Gilead Sciences GILD Stock Holding History

FWL Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Buy
+13
New +$1.71K ﹤0.01% 433
2024
Q1 		– Sell
-402
Closed -$30.9K – 245
2023
Q4 		$32.6K Buy
+402
New +$31.3K 0.02% 111
2023
Q1 		– Sell
-160
Closed -$13.7K – 117
2022
Q4 		$13.7K Buy
+160
New +$12.7K 0.01% 128

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FWL Investment Management's GILD Position: Q2 2026 in Review

FWL Investment Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 13 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: FWL Investment Management previously reported a position in GILD as recently as Q4 2023.

FWL Investment Management first reported a position in GILD in Q4 2022 and has held it in 3 quarters since. The position peaked at $32.6K in Q4 2023. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • FWL Investment Management held 13 shares of Gilead Sciences worth $1.64K as of Q2 2026.
  • Gilead Sciences was a new FWL Investment Management position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of FWL Investment Management's portfolio in Q2 2026, its #433 holding.
  • FWL Investment Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 3 quarters since.
  • FWL Investment Management's Gilead Sciences position peaked at $32.6K in Q4 2023.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.